Status:
COMPLETED
Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Acquired Bleeding Disorder
Trauma
Eligibility:
All Genders
18-85 years
Brief Summary
This study is conducted in North America. The purpose of this study is to evaluate the occurrence and severity of bleeding in brain injury and to identify important safety issues following traumatic b...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Ages Eligible for Study: 18 Years - 85 Years
Exclusion
Key Trial Info
Start Date :
October 6 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 23 2005
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT00124293
Start Date
October 6 2004
End Date
November 23 2005
Last Update
February 27 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Plainsboro, New Jersey, United States, 08536
2
Novo Nordisk Investigational Site
Mississauga, Canada, L4W 4XI